Baxter International Inc. (BAX)
$24.89+0.44%Close
BUYRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV17.3%–103.2%
- Market cap
- $12.9B
- Beta
- 0.65
- Div yield
- 0.16%
- P/E (TTM)
- -12.20
- IV-%ile
- 31
- IV ATM
- 38.5%
- Short % float
- 4.76%
- Days to cover
- 3.0
- SI change
- +4.9%
- 1W
- +2.18%
- 1M
- +4.32%
- vs SPY 1W
- +2.31%
- vs SPY 1M
- +1.81%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 28
- GARP
- 1
- TYPE
- Value / Recovery (blended)
Composite of Value · Growth · GARP
ROIC-10.0%
REV YoY-
ROE-16.6%
EPS YoY-
ROA-5.4%
GROSS30
OP-2
NET-9
[VALUATION]
P/E TTM-12.20
P/E FWD13.78
SECTOR PE20.34
INDUSTRY PE45.85
P/B2.07
P/FCF-
EV/EBITDA27.18
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E155.77
ALTMAN Z-
CURR RATIO1.95
ND/EBITDA-
BETA0.65
Company news
FAQ
- What is LOPJLB’s current signal on BAX?
- LOPJLB’s latest quantitative signal on Baxter International Inc. (BAX) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is BAX in?
- Baxter International Inc. (BAX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Baxter International Inc. (BAX) do?
- Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and de…